🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)

Recruitingn/aAges 18 Years - anyAllUniversitätsklinikum Hamburg-Eppendorf
NCT04848844 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Advances in surgical and medical care have led to improved outcomes in patients with congenital heart disease (CHD). As a consequence, the majority of patients nowadays survives to adulthood (adults with CHD, that is, adult CHD \[ACHD\]) with good quality of life. Despite the surgical success, the morbidity and mortality of ACHD is higher than in the general population and is linked to the development of heart failure (HF) in adulthood. HF occurs in approximately 25% of patients with ACHD, even in those patients in whom the congenital mal-formation has been corrected successfully in childhood. The time course and presentation are heterogeneous owing to variable congenital malformation and limitation of treatment options. ACHD with an anatomic right ventricle as the systemic ventricle (e.g., atrial switch operation in patients with transposition of the great arteries \[TGAs\]) and those

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. The patient has to be listed as an adult transplant candidate in the country the data is obtained with an age ≥18 years 2. The patient has to have a congenital heart defect or an inherited cardiomyopathy (specific; hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy or non-compaction cardiomyopathy) which is often included into the category ACHD 3. Data is obtained from the first evaluation for listing or listing for heart-only or heart-combined organ transplantation 4. Transfer of anonymised data 5. The institution/organization agrees to the memorandum how data is managed, and scientific cooperation is planned between all institutions Exclusion Criteria: a. The patient is listed for a second heart transplantation (retransplantation)
💊

What it tests

  • Not listed
📍

Where

1 site
University Heart and Vascular Center Hamburg
Hamburg, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy